NSN 6505-00-584-2338
Part Details | EXTENDED PHENYTOIN SODIUM CAPSULES
6505-00-584-2338
Alternate Parts: NDC00071036232, NDC00071-0362-32, NDC65162021211, NDC65162-0212-11, NDC10135060310, NDC10135-0603-10, NDC00378156010, NDC00378-1560-10, NDC00071036932, NDC00071-0369-32, NDC51672411103, NDC51672-4111-03, 6505-00-584-2338, 00-584-2338, 6505005842338, 005842338
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JAN 01, 1963 | 00-584-2338 | 33946 ( PHENYTOIN SODIUM CAPSULES, EXTENDED ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-00-584-2338
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00071-0362-32 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC65162-0212-11 | 557X3 | AMNEAL PHARMACEUTICALS OF NEW YORK,LLC |
| NDC10135-0603-10 | 1TAP7 | MARLEX PHARMACEUTICALS, INC. |
| NDC00378-1560-10 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC00071-0369-32 | 86491 | PFIZER INC.DBA PFIZER |
| NDC51672-4111-03 | 3HFB6 | TARO PHARMACEUTICALS U.S.A., INC. |
Technical Data | NSN 6505-00-584-2338
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | HARD |
| CAPSULE CONTENT FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB100.000 MILLIGRAMS PHENYTOIN SODIUM |
| PRIMARY CONTAINER TYPE | BOTTLE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 |
| SUPPLEMENTARY FEATURES | D-DAY ITEM FOR DOD |
| SPECIAL FEATURES | STORE AT 20 TO 25 C (68 TO 77 F) ?SEE USP CONTROLLED ROOM TEMPERATURE| PROTECT FROM LIGHT AND MOISTURE. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PHENYTOIN SODIUM CAPSULES EXTENDED USP 100MG 1000 BT |